Keywords: bayer/schering, ag, present, pipeline, highlighting, nexavar, campath

Bayer/Schering AG present R&D pipeline, highlighting Nexavar, Campath and Yaz

Article | 06 November 2006

Print This

At its 2006 "Perspective on Innovation" event at its Leverkusen Communications center, German drug and chemicals group Bayer AG discussed the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in